Predicting the efficacy of variant-modified COVID-19 vaccine boosters
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predicting the efficacy of variant-modified COVID-19 vaccine boosters
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 29, Issue 3, Pages 574-578
Publisher
Springer Science and Business Media LLC
Online
2023-03-03
DOI
10.1038/s41591-023-02228-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody Response to Omicron BA.4–BA.5 Bivalent Booster
- (2023) Qian Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1
- (2023) Jessica Miller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial
- (2022) Deborah Cromer et al. CLINICAL INFECTIOUS DISEASES
- SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
- (2022) Rolando Pajon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
- (2022) Peter B. Gilbert et al. SCIENCE
- Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine
- (2022) Odile Launay et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial
- (2022) Spyros Chalkias et al. NATURE MEDICINE
- A Bivalent Omicron-Containing Booster Vaccine against Covid-19
- (2022) Spyros Chalkias et al. NEW ENGLAND JOURNAL OF MEDICINE
- Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach
- (2022) Bhargava Kandala et al. EBioMedicine
- Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster
- (2022) Chaitanya Kurhade et al. NATURE MEDICINE
- Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial
- (2022) Youyi Fong et al. Nature Microbiology
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
- (2021) Adam K. Wheatley et al. Nature Communications
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
- (2021) Angela Choi et al. NATURE MEDICINE
- Evidence for antibody as a protective correlate for COVID-19 vaccines
- (2021) Kristen A. Earle et al. VACCINE
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
- (2021) Shuo Feng et al. NATURE MEDICINE
- mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
- (2021) Rishi R. Goel et al. SCIENCE
- Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
- (2021) Deborah Cromer et al. Lancet Microbe
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More